Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,220 | 67,412,751 | 0.60% | 0.64% | 3.95% | 17.11% | 5.80% | 14.66% |
| Healthcare | HEALTHCARE | Sector | 1,187 | 6,141,984 | 0.76% | 0.41% | 0.40% | 0.84% | -2.54% | -7.21% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 613 | 2,963,375 | 1.50% | 1.41% | 0.90% | 6.40% | 3.51% | -9.71% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 289 | 1,243,351 | 1.86% | 1.80% | -0.42% | 5.87% | 3.84% | -8.45% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 93 | 92,294 | 2.79% | 2.65% | -2.82% | 12.49% | -13.57% | -21.59% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| SAGE Therapeutics, Inc. | SAGE:USASAGE:USA | Stock | 1 | 575 | 0.44% | 1.32% | 34.31% | 43.97% | 47.91% | -15.90% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 918 | 5.59% | 15.33% | 30.11% | 41.58% | -17.93% | 138.58% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 960 | 6.98% | 21.70% | 23.84% | 72.58% | 72.00% | 40.98% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 1,021 | 7.36% | 16.28% | 12.66% | 75.52% | -35.88% | 18.45% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 678 | 15.56% | 17.43% | 11.88% | 41.92% | -22.00% | -25.29% |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 511 | 11.01% | 23.87% | 10.66% | 60.67% | -22.12% | -42.27% |
| ATAI Life Sciences NV | ATAI:USAATAI:USA | Stock | 1 | 531 | 1.14% | -1.85% | 10.37% | 119.83% | 49.44% | 109.45% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,509 | 8.03% | 9.57% | 8.06% | 51.16% | -13.70% | 370.01% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 656 | 0.08% | 3.18% | 7.90% | 103.73% | 9.07% | -7.11% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 13,217 | 3.71% | 4.30% | 6.48% | 52.51% | -2.44% | -6.14% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,270 | 90,221,780 | 0.60% | 1.04% | 4.47% | 26.07% | 5.45% | 13.79% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 2,503 | 4.01% | 1.84% | 3.29% | 15.76% | -19.74% | -12.13% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,179 | 4.68% | 7.53% | 2.04% | 30.78% | -24.32% | -29.21% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 6,877 | 2.26% | 1.97% | 0.42% | 8.54% | -8.39% | 10.81% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 5,530 | 3.63% | 9.11% | 0.39% | 15.17% | 31.97% | 34.36% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 19,487 | -1.07% | 2.27% | -0.08% | 16.63% | -13.21% | -41.68% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 583 | 3.35% | 15.57% | -0.90% | 57.87% | 0.39% | 13.03% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 1,829 | 1.81% | 2.67% | -1.45% | 6.63% | -11.82% | 24.50% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,605 | 2.62% | 0.98% | -1.87% | 52.98% | 23.54% | 32.17% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 93 | 92,294 | 2.79% | 2.65% | -2.82% | 12.49% | -13.57% | -21.59% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,968 | 4.70% | 7.06% | -3.68% | 21.90% | -0.61% | 5.38% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 4,942 | 2.04% | 3.43% | -5.46% | 6.35% | 5.30% | 23.02% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 3,861 | 2.29% | 0.31% | -6.50% | 22.55% | 6.47% | 53.61% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,341 | 8.22% | 9.91% | -7.55% | 22.63% | -46.95% | -32.65% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 521 | 4.96% | 8.55% | -10.56% | 124.78% | 23.90% | 14.41% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,478 | 3.87% | 3.72% | -14.97% | -12.45% | -62.75% | -58.03% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 2,637 | 4.22% | 2.05% | -16.41% | 1.05% | 7.11% | 39.97% |
| Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 522 | 12.29% | 17.73% | -19.75% | 31.26% | -23.87% | 139.41% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,009 | 5.84% | 2.30% | -39.59% | 30.40% | -63.86% | -73.58% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 1,903 | 1.79% | 9.37% | -54.96% | -60.71% | -84.85% | -87.21% |
* Colors indicate performance relative to the benchmark.